Molecularly, this reprogramming involves coordinated changes in transporters (like LAT1), enzymes (BCAT1/2, BCKDH, BCKDK), and signaling pathways (mTORC1 and beyond) that together promote tumor proliferation, survival under stress, and metastasis. This evidence concerns the gene BCKDK and neoplasm.